sellWeak cluster of 210b5-1 plan
Edris Badreddin sold $839k of SWTX
Chief Operating Officer at SpringWorks Therapeutics, Inc.. 20,000 shares at an average of $41.97, traded Dec 3, 2024, filed Dec 5, 2024.
Warning score
31Value
$839k
20,000 shares
Holdings after
209,600
-9% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-24-125969, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 3, 2024 | SOpen-market sale Common Stock10b5-1 | -11,966 | $41.78 | $500k | 217,634 | Dec 5, 2024 |
| Dec 3, 2024 | SOpen-market sale Common Stock10b5-1 | -8,034 | $42.24 | $339k | 209,600 | Dec 5, 2024 |
Related signals
Other insiders at SpringWorks Therapeutics, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 2Weak | sell10b5-1 | SWTX SpringWorks Therapeutics, Inc. | Ashar Bhavesh Chief Commercial Officer | $62k | 1,016 | |
| 38Weak | sell 210b5-1 | SWTX SpringWorks Therapeutics, Inc. | Islam Saqib Chief Executive Officer | $2.0M | 49,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.